Effect of nitric-oxide synthesis on tumour blood volume and vascular activity: a phase I study.

Effect of nitric-oxide synthesis on tumour blood volume and vascular activity: a phase I study.

BACKGROUND: Nitric oxide has been implicated in tumour angiogenesis and in the maintaining of vasodilator tone of tumour blood vessels. The tumour vascular effects of inhibition of nitric-oxide synthesis have not been investigated in patients with cancer. METHODS: Seven women and 11 men (12 with non...

Full description

Bibliographic Details
Main Authors:	Ng, Q, Goh, V, Milner, J, Stratford, MR, Folkes, L, Tozer, G, Saunders, M, Hoskin, P
Format:	Journal article
Language:	English
Published:	2007

Similar Items

Effects of combretastatin A4 phosphate on endothelial cell morphology in vitro and relationship to tumour vascular targeting activity in vivo.
by: Galbraith, S, et al.
Published: (2001)

Nitric oxide production by tumour tissue: impact on the response to photodynamic therapy.
by: Korbelik, M, et al.
Published: (2000)

Effect of local radiotherapy for bone pain on urinary markers of osteoclast activity.
by: Hoskin, P, et al.
Published: (2000)

The vascular response of tumor and normal tissues in the rat to the vascular targeting agent, combretastatin A-4-phosphate, at clinically relevant doses.
by: Prise, V, et al.
Published: (2002)

Influence of plasma glutathione levels on radiation mucositis.
by: Wardman, P, et al.
Published: (2001)

A validated HPLC method with fluorescence detection for the glucuronides of Combretastatin A1 in human plasma, and studies on their cis-trans isomerisation.
by: Stratford, MR, et al.
Published: (2012)

Validation of a method for the determination of the anticancer agent Combretastatin A1 phosphate (CA1P, OXi4503) in human plasma by HPLC with post-column photolysis and fluorescence detection.
by: Stratford, MR, et al.
Published: (2011)

Quantitative determination of the anticancer prodrug combretastatin A1 phosphate (OXi4503, CA1P), the active CA1 and its glucuronide metabolites in human urine and of CA1 in plasma by HPLC with mass spectrometric detection.
by: Stratford, MR, et al.
Published: (2012)

Tumour vascular disrupting agents: combating treatment resistance.
by: Tozer, G, et al.
Published: (2008)

The role of nitric oxide as a hypoxic cell radiosensitizer
by: Folkes, L
Published: (2013)

Phase I clinical and pharmacokinetic evaluation of the vascular-disrupting agent OXi4503 in patients with advanced solid tumors.
by: Patterson, D, et al.
Published: (2012)

Hypoxic radiosensitization by nitric oxide
by: Folkes, L, et al.
Published: (2012)

Results of a phase II clinical trial of 6-mercaptopurine (6MP) and methotrexate in patients with BRCA-defective tumours
by: Roberts, C, et al.
Published: (2019)

A validated HPLC method with fluorescence detection for the glucuronides of Combretastatin A1 in human plasma, and studies on their cis-trans isomerisation
by: Stratford, M, et al.
Published: (2012)

Validation of a method for the determination of the anticancer agent Combretastatin A1 phosphate (CA1P, OXi4503) in human plasma by HPLC with post-column photolysis and fluorescence detection
by: Stratford, M, et al.
Published: (2011)

Evaluation of the anti-vascular effects of combretastatin in rodent tumours by dynamic contrast enhanced MRI.
by: Maxwell, R, et al.
Published: (2002)

Kinetics of the reaction between nitric oxide and glutathione: implications for thiol depletion in cells.
by: Folkes, L, et al.
Published: (2004)

Modification of DNA damage mechanisms by nitric oxide during ionizing radiation.
by: Folkes, L, et al.
Published: (2013)

Intravital imaging of tumour vascular networks using multi-photon fluorescence microscopy.
by: Tozer, G, et al.
Published: (2005)

Nitric oxide and vascular disease
by: Shirodaria, C, et al.
Published: (2007)

Safety and feasibility of ultrasound-triggered targeted drug delivery of doxorubicin from thermosensitive liposomes in liver tumours (TARDOX): a single-centre, open-label, phase 1 trial
by: Lyon, PC, et al.
Published: (2018)

DNA damage induced by nitric oxide during ionizing radiation is enhanced at replication
by: Folkes, L, et al.
Published: (2013)

DNA damage induced by nitric oxide during ionizing radiation is enhanced at replication.
by: Folkes, L, et al.
Published: (2013)

Vascular hamartoma and vascular tumours of orbit
by: Nath K, et al.
Published: (1977-01-01)

Blood and urine concentrations of vascular endothelial growth factor in dogs with tumours
by: Ts. Hristov, et al.
Published: (2021-12-01)

Nitric oxide synthase inhibition enhances the tumor vascular-damaging effects of combretastatin a-4 3-o-phosphate at clinically relevant doses.
by: Tozer, G, et al.
Published: (2009)

Radiosensitization by nitric oxide at low radiation doses.
by: Wardman, P, et al.
Published: (2007)

Modelling the interactions between tumour cells and a blood vessel in a microenvironment within a vascular tumour
by: Breward, C, et al.
Published: (2001)

Oxidative metabolism of combretastatin A-1 produces quinone intermediates with the potential to bind to nucleophiles and to enhance oxidative stress via free radicals.
by: Folkes, L, et al.
Published: (2007)

5-Fluoroindole-3-acetic acid: a prodrug activated by a peroxidase with potential for use in targeted cancer therapy.
by: Folkes, L, et al.
Published: (2002)

Nitric oxide-superoxide interactions in human blood vessels: implications for vascular peroxynitrite formation
by: Guzik, T, et al.
Published: (2001)

ZD6126: a novel vascular-targeting agent that causes selective destruction of tumor vasculature.
by: Davis, P, et al.
Published: (2002)

In vivo characterization of horseradish peroxidase with indole-3-acetic acid and 5-bromoindole-3-acetic acid for gene therapy of cancer.
by: Tupper, J, et al.
Published: (2010)

Modelling the response of vascular tumours to chemotherapy: A multiscale approach
by: Byrne, H, et al.
Published: (2006)

The development of tumour vascular networks
by: Anahita Fouladzadeh, et al.
Published: (2021-09-01)

Tumour volume distribution can yield information on tumour growth and tumour control
by: Uwe Schneider, et al.
Published: (2022-05-01)

Effects of fumarate on renal vascular reactivity and the modulation of blood pressure in normotensive rats: Possible contribution of the nitric oxide synthase-nitric oxide system
by: Osaze Edosuyi, et al.
Published: (2022-08-01)

Oscillatory dynamics in a model of vascular tumour growth--implications for chemotherapy.
by: Stamper, I, et al.
Published: (2010)

Piggyback eprom microcomputers offer flexibility for low volume applications /
by: 274546 Folkes, Don

The impact of cell crowding and active cell movement on vascular tumour growth
by: Betteridge, R, et al.
Published: (2006)